menu search

DOCS / 3 Top Stocks That Just Went on Sale

3 Top Stocks That Just Went on Sale
Enphase is the cheapest it has ever been on a free-cash-flow basis. Toro hopes to restart sales growth, armed with a new Lowe's partnership. Read More
Posted: Sep 24 2023, 05:47
Author Name: The Motley Fool
Views: 112427

DOCS News  

Doctors have a new way to scrub personal information from internet after spike in harassment

By CNBC
November 1, 2023

Doctors have a new way to scrub personal information from internet after spike in harassment

Doximity announced a free new service called DocDefender that can remove a physician's personal phone numbers and addresses from public websites more_horizontal

MD or DOCS: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 3, 2023

MD or DOCS: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of thes more_horizontal

1 Growth Stock Down 39% to Buy and Hold for 10 Years

By The Motley Fool
September 25, 2023

1 Growth Stock Down 39% to Buy and Hold for 10 Years

Doximity's valuation and slowing sales growth are turning off many investors. Despite these issues, there is a lot to like about the company, includin more_horizontal

3 Top Stocks That Just Went on Sale

By The Motley Fool
September 24, 2023

3 Top Stocks That Just Went on Sale

Enphase is the cheapest it has ever been on a free-cash-flow basis. Toro hopes to restart sales growth, armed with a new Lowe's partnership. more_horizontal

1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years

By The Motley Fool
August 16, 2023

1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years

Doximity is profitable and boasts high gross and net margins. The company's platform displays the flywheel effect, a powerful moat. more_horizontal

Down 39.9%, Is Doximity a Buy on the Dip?

By The Motley Fool
August 14, 2023

Down 39.9%, Is Doximity a Buy on the Dip?

Doximity shares recently fell in response to a revised forward outlook management shared during its fiscal first-quarter earnings report. Over half a more_horizontal

Time to Cut and Run on This 1 Formerly Promising Digital Health Stock?

By The Motley Fool
August 12, 2023

Time to Cut and Run on This 1 Formerly Promising Digital Health Stock?

Doximity's revised guidance for the current fiscal year was horrendous. The business is still growing a bit and is highly profitable. more_horizontal

Why Doximity Stock Plunged 29% This Week

By The Motley Fool
August 11, 2023

Why Doximity Stock Plunged 29% This Week

Doximity announced solid fiscal first-quarter 2024 results that exceeded expectations. But the online networking service for medical professionals is more_horizontal


Search within

Pages Search Results: